These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 12141718

  • 21. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis.
    Meltzer EO, Casale TB, Nathan RA, Thompson AK.
    Ann Allergy Asthma Immunol; 1999 Oct; 83(4):311-7. PubMed ID: 10541423
    [Abstract] [Full Text] [Related]

  • 22. Efficacy comparison of levocetirizine vs montelukast in ragweed sensitized patients.
    Patel P, Patel D.
    Ann Allergy Asthma Immunol; 2008 Sep; 101(3):287-94. PubMed ID: 18814452
    [Abstract] [Full Text] [Related]

  • 23. Effects of fexofenadine on the early response to nasal allergen challenge.
    Allocco FT, Votypka V, deTineo M, Naclerio RM, Baroody FM.
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
    [Abstract] [Full Text] [Related]

  • 24. Addition of ibuprofen to pseudoephedrine and chlorpheniramine in the treatment of seasonal allergic rhinitis.
    Meltzer EO, Berman GD, Corren J, Pedinoff AJ, Doyle G, Waksman JA, Butkerait P, Cooper SA, Berlin RG, Wason S.
    Ann Allergy Asthma Immunol; 2004 Nov; 93(5):452-9. PubMed ID: 15562884
    [Abstract] [Full Text] [Related]

  • 25. Safety and efficacy of terfenadine/pseudoephedrine versus clemastine/phenylpropanolamine in the treatment of seasonal allergic rhinitis.
    Segal AT, Falliers CJ, Grant JA, Podleski WK, Woehler TR, Huster WJ, McNutt B.
    Ann Allergy; 1993 May; 70(5):389-94. PubMed ID: 8498730
    [Abstract] [Full Text] [Related]

  • 26. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.
    Nelson HS, Reynolds R, Mason J.
    Ann Allergy Asthma Immunol; 2000 May; 84(5):517-22. PubMed ID: 10831005
    [Abstract] [Full Text] [Related]

  • 27. Onset of action of intranasal budesonide (Rhinocort aqua) in seasonal allergic rhinitis studied in a controlled exposure model.
    Day JH, Briscoe MP, Rafeiro E, Ellis AK, Pettersson E, Akerlund A.
    J Allergy Clin Immunol; 2000 Mar; 105(3):489-94. PubMed ID: 10719298
    [Abstract] [Full Text] [Related]

  • 28. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
    Day JH, Briscoe MP, Rafeiro E, Hewlett D, Chapman D, Kramer B.
    Allergy Asthma Proc; 2004 Mar; 25(1):59-68. PubMed ID: 15055564
    [Abstract] [Full Text] [Related]

  • 29. Brompheniramine, terfenadine, and placebo in allergic rhinitis.
    Klein GL, Littlejohn T, Lockhart EA, Furey SA.
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):365-70. PubMed ID: 8933774
    [Abstract] [Full Text] [Related]

  • 30. Comparison of cetirizine-pseudoephedrine and placebo in patients with seasonal allergic rhinitis and concomitant mild-to-moderate asthma: randomized, double-blind study.
    Nathan RA, Finn AF, LaForce C, Ratner P, Chapman D, de Guia EC, Hewlett D, Kramer B.
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):389-96. PubMed ID: 17042147
    [Abstract] [Full Text] [Related]

  • 31. Cetirizine and pseudoephedrine retard, given alone or in combination, in patients with seasonal allergic rhinitis.
    Grosclaude M, Mees K, Pinelli ME, Lucas M, Van de Venne H.
    Rhinology; 1997 Jun; 35(2):67-73. PubMed ID: 9299654
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
    Pleskow W, Grubbe R, Weiss S, Lutsky B.
    Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
    [Abstract] [Full Text] [Related]

  • 33. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.
    Howarth PH, Stern MA, Roi L, Reynolds R, Bousquet J.
    J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734
    [Abstract] [Full Text] [Related]

  • 34. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H, Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group.
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [Abstract] [Full Text] [Related]

  • 35. Effectiveness of azelastine nasal solution in seasonal allergic rhinitis.
    Storms WW, Pearlman DS, Chervinsky P, Grossman J, Halverson PC, Freitag JJ, Widlitz MD.
    Ear Nose Throat J; 1994 Jun; 73(6):382-6, 390-4. PubMed ID: 8076537
    [Abstract] [Full Text] [Related]

  • 36. Double-blind assessment of azelastine in the treatment of perennial allergic rhinitis.
    Grossman J, Halverson PC, Meltzer EO, Shoenwetter WF, van Bavel JH, Woehler TR, Freitag JJ, Hemsworth GR.
    Ann Allergy; 1994 Aug; 73(2):141-6. PubMed ID: 8067597
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of a paracetamol-pseudoephedrine combination for treatment of nasal congestion and pain-related symptoms in upper respiratory tract infection.
    Eccles R, Jawad M, Jawad S, Ridge D, North M, Jones E, Burnett I.
    Curr Med Res Opin; 2006 Dec; 22(12):2411-8. PubMed ID: 17257455
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders.
    Prenner BM, Capano D, Harris AG.
    Clin Ther; 2000 Jun; 22(6):760-9. PubMed ID: 10929922
    [Abstract] [Full Text] [Related]

  • 39. Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis.
    Casale TB, Andrade C, Qu R.
    Allergy Asthma Proc; 1999 Jun; 20(3):193-8. PubMed ID: 10389553
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis.
    Chervinsky P, Nayak A, Rooklin A, Danzig M.
    Allergy Asthma Proc; 2005 Jun; 26(5):391-6. PubMed ID: 16450574
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.